For adult patients | TRODELVY® (sacituzumab govitecan-hziy)
Discover TRODELVY® (sacituzumab govitecan‐hziy) for treatment guidance, clinical trial results, addressing side effects, and patient support services. See Important Facts & Important Warning. You are now leaving Trodelvy.com
How TRODELVY Works | TRODELVY® (sacituzumab govitecan-hziy)
TRODELVY is designed to work differently than traditional chemo TRODELVY targets cells with Trop-2. TRODELVY is a type of treatment called an antibody-drug conjugate (ADC). An ADC is a substance that binds to a specific protein or receptor found on certain types of …
For adult patients | TRODELVY® (sacituzumab govitecan-hziy)
Learn more about TRODELVY® (sacituzumab govitecan‐hziy) in pretreated mTNBC, including clinical trial results, dosing, and support services. For adult patients. See Important Facts & Important Warning.
FAQ | TRODELVY® (sacituzumab govitecan-hziy)
For adult patients. Answers to FAQs on TRODELVY® (sacituzumab govitecan‐hziy) treatment and patient concerns. See Important Facts & Important Warning.
Dosing Information | TRODELVY® (sacituzumab govitecan-hziy)
How TRODELVY® (sacituzumab govitecan-hziy) is given, what to expect on treatment days, and next steps after treatment. For adult patients. See Important Facts & Important Warning.
Addressing Side Effects | TRODELVY® (sacituzumab govitecan-hziy)
Get detailed information on planning potential strategies for some side effects of TRODELVY® (sacituzumab govitecan‐hziy) for adult patients with pretreated mTNBC. See Important Facts & Important Warning.
Clinical Trial Results | TRODELVY® (sacituzumab govitecan-hziy)
Researchers tested TRODELVY in a phase 3 clinical trial of 543 adults with previously treated* HR+/HER2- mBC comparing TRODELVY to traditional chemotherapy to find out how long people: arrow_forward Lived without HR+/HER2- mBC progressing
- [PDF]
TRODELVY
TRODELVY is a prescription medicine used to treat adults with • a type of breast cancer that is estrogen and progesterone hormone receptor (HR) negative, and human epidermal growth factor receptor 2 (HER2)-negative (also called triple-negative breast cancer).
Patient Stories | TRODELVY® (sacituzumab govitecan‐hziy)
Stories about treatment days, side effects, treatment experiences, and more from people receiving TRODELVY® (sacituzumab govitecan‐hziy) for adults with pretreated HR+/HER2‐ metastatic breast cancer.
For adult patients | TRODELVY® (sacituzumab govitecan‐hziy)
For adult patients. Discover TRODELVY® (sacituzumab govitecan‐hziy). Sign up for resources and support. See Important Facts & Important Warning.